196 Views | 344 Downloads
Corresponding author: Stewart A. Factor, Email: sfactor@emory.edu
See publication for full list of author contributions.
J.L.M. has no competing interests, F.C.G. has no competing interests, B.S. has no competing interests, D.B. has no competing interests, S.P.P. has no competing interests, S.A.F. has the following competing interests: Honoraria: Lundbeck, Teva, Sunovion, Biogen, Acadia, Neuroderm, Acorda, CereSpire.
Grants: Ipsen, Medtronics, Boston Scientific, Teva, US World Meds, Sunovion Therapeutics, Vaccinex, Voyager, Jazz Pharmaceuticals, Lilly, CHDI Foundation, Michael J. Fox Foundation, NIH, Royalties: Demos, Blackwell Futura for textbooks, Uptodate, Other Bracket Global LLC, CNS Ratings LLC.
The content is solely the responsibility of the authors and does not necessarily reflect the official views of the National Institutes of Health.
Additional gait assessments were completed by Garrett Alexander M.D., Ph.D. Serum levodopa levels were completed by the Emory HPLC Bioanalytical Core (EHBC), which was supported by the Department of Pharmacology, Emory University School of Medicine and the Georgia Clinical & Translational Science Alliance of the National Institutes of Health under Award Number UL1TR002378.
The study was funded by Curtis Family Fund, Sartain Lanier Family Foundation (S.A.F.), NIH K25HD086276 (J.L.M.), and Parkinson Foundation Fellowship (S.P.P.)
© The Author(s) 2019